JLPC(SH:600513) Sou Hu Cai Jing·2026-01-09 07:05Core Viewpoint - Lianhuan Pharmaceutical experienced a stock price surge, reaching the daily limit on January 9, indicating strong market interest and potential investor confidence in the company [1]. Group 1: Company Overview - Lianhuan Pharmaceutical's primary business encompasses pharmaceutical manufacturing and distribution [3]. Group 2: Industry Developments - The Guangzhou Municipal Government has issued a plan titled "Guangzhou Accelerates the Construction of an Advanced Manufacturing Powerhouse (2024-2035)," which emphasizes the acceleration of innovative drug strategies and the development of monoclonal antibodies, vaccines, blood products, and diagnostic reagents in the biopharmaceutical sector [3]. - The plan aims to address major health issues and advance cutting-edge biotechnologies, targeting breakthroughs in gene engineering, new drug targets and mechanisms, synthetic biology, and bioinformatics [3]. - Leveraging the unique advantages of Lingnan traditional Chinese medicine, the initiative seeks to promote the standardization and internationalization of traditional medicine, creating a comprehensive industrial chain from raw materials to pharmaceuticals [3]. - By 2035, the goal is to establish a leading position in the biopharmaceutical and high-end medical device industries, with an industrial scale reaching 500 billion [3].